Stocks in play: BioVaxys Technology Corp
Announces it has appointed Christopher Cherry as Chief Financial Officer. Mr. Cherry, a Chartered Accountant and Certified Public Accountant, has extensive experience, having served as a CFO of many public issuers in a broad range of sectors. Mr. Cherry has previously worked as a Senior Auditor with Davidson & Company LLP and a Senior Accountant with KPMG LLP. BioVaxys Technology Corp shares C.BIOV are trading unchanged at $0.07.
Read:
Multi-Billion-Dollar Offers Not Enough to Get Lithium Asset Owners to Bite for Mining Giants
The Future of Corporate Innovation Explores the Expanding Role of Artificial Intelligence
Navigating the Surge in Aquaculture: Opportunities & Challenges
Tech Sector’s AI Advancements Boosting Economic Momentum, Reshaping 90% of US Jobs
More Safe and Secure Lithium Being Sought by the World’s Auto Giants in EV Production